Results of infusion of pleural and peritoneal calcinoses with colloidal radiogold Au-198

This study begins with a general part, containing a description of the usual techniques, a summary of the side effects and complications and also a survey over the indications and contra-indications. This chapter is followed by the evaluation of the histologies taken of 572 patients with 744 applications. These patients received infusions of Au-198 intrapleurally and/or intraperitoneally between Januray 1st, 1960 and December 31st, 1970, in the Rudolf-Virchow Hospital, Berlin. The consideration of the overall patient population is followed by a classification of the individual primary tumours according to various aspects. In order to judge about the effectiveness of the applied radiogold therapy, we calculated the average survival times of the individual patient groups and additionally we assessed the influence due to effusion. For the 155 patients who received radiogold intrapleurally once, a rate of success of 56.1% resulted; this rate was 58.8% for the 58 patients suffering from carcinoma of the breast, and for the 59 patients with bronchial carcinoma this rate was 56.1%. Correspondingly we calculated a rate of success of 40.4% for 94 patients with intraperitoneal radiogold infusion and ascites. In the 57 patients suffering from ovarian tumours and ascites, we found a rate of success of 57.9%. Ten patients, who received radiogold not only intrapleurally, but also intraperitoneally, showed a mean survival rate of 16 months. (orig./MG)